Hospital denial rate: how to calculate and interpret it

Measuring denials is the first step to preventing them. The hospital denial rate shows whether the problem is growing or shrinking, which payer accounts for the most cases and where the internal process needs to be adjusted.

According to the Anahp Observatory 2025 (National Association of Private Hospitals), the initial denial rate at Brazilian private hospitals reached 15.89% of gross revenue from health plans in 2024, equivalent to R$ 5.8 billion withheld by payers. The industry’s historical benchmark was between 3% and 5% at the start of the decade. The growth is consistent: roughly 9% in 2022, 11.8% in 2023 and almost 16% in 2024.

This article explains how to calculate the hospital denial rate, how to interpret the result and how to use that number to protect the hospital’s revenue cycle.

What a denial is and which rates measure it

A denial is the total or partial refusal, by the health plan, of an item charged on the hospital claim. It can originate in coding errors (technical denial), in questions about the clinical need for the procedure (clinical denial) or in discrepancies between what was charged and what is set out in the contract with the payer (administrative denial).

For a complete view of classification and causes, read the article Denials: learn what they are and how to prevent them.

Two rates work together to measure the impact of denials. Each one answers a different question, and reading them together brings precision to the analysis.

Initial denial rate

It measures the percentage of gross billing denied by the payer in the first review of the claim, before any appeal. It reflects the gross volume of the problem: everything the payer rejected at first contact, for any reason. It is the most immediate measure for detecting whether billing processes are frequently producing inconsistencies.

Accepted denial rate

It measures the percentage of gross billing that remains denied after the appeal process has closed. It represents the actual financial loss: the amount the hospital billed, did not receive and did not recover.

The difference between them is the volume of denials the hospital is managing to reverse through appeals. When the initial rate is high and the accepted rate is low, the hospital bills consistently but spends time and staff disputing charges that were legitimate. When both rise together, the problem lies in internal billing and documentation processes.

The Anahp Observatory 2025 recorded an accepted denial rate of 1.96% of gross revenue from health plans in 2024, against an initial denial rate of 15.89%. The gap between the two numbers confirms that most of what was denied came from the source. The cost lies in the recovery process: staff time and a longer time to payment.

How to calculate the hospital denial rate

Both formulas start from the same basis: divide the denied amount by the reference amount and multiply by 100 to get the percentage.

Initial denial rate

(Amount denied in the first review ÷ Total amount billed) × 100

Accepted denial rate

(Accepted denial amount ÷ Total amount billed) × 100

The reference amount is always gross revenue from health plans, before any discount or contractual adjustment. Using net revenue as the basis distorts the result and makes comparison with industry benchmarks impossible.

A practical example: the denial that starts in the price table

A hospital bills R$ 2,000,000 in a month to health plans. In the first review, the payers deny R$ 280,000, equivalent to 14% of gross billing: that is the period’s initial denial rate.

After the appeal process, the hospital recovers R$ 240,000. The remaining R$ 40,000 are recognized as legitimate denials and recorded as a loss. The accepted denial rate for the month is 2% (R$ 40,000 ÷ R$ 2,000,000 × 100).

Of the R$ 240,000 recovered, part originated in a preventable administrative error: room daily rates billed with the private-room code when the contract with that payer provided for a ward. The item was charged correctly in care terms, but not in line with the contractual price table in force.

This type of discrepancy is common at hospitals that serve multiple payers, each with its own tables and rules. The billing team needs to know the specifics of each contract, and any contractual update must be reflected immediately in the billing systems.

This is where technology reduces risk structurally. Revenue cycle management platforms can automatically cross-check every billed item against the rules of the corresponding payer’s contract before the claim is submitted. A discrepancy that would take days to identify in a retrospective audit is flagged before billing, when it can still be corrected without generating a denial.

How to interpret the result: where the hospital stands

Calculating the rate is the starting point, and interpretation is what turns the number into a decision.

The first benchmark is the industry’s historical behavior. The table below shows how the initial denial rate has evolved at Brazilian private hospitals, based on data from the Anahp Observatory 2025.

Reading the table reveals two simultaneous movements: the initial denial rate more than tripled in three years, and the accepted denial rate also grew, albeit to a lesser extent. This indicates that part of the increase reflects improper denials, which hospitals are managing to reverse, but at the cost of more time and more appeal effort.

The consolidated number is not enough

A consolidated rate of 14% can hide very different realities across payers. One of them may account for 60% of cases because it requires specific documentation the team has not yet mastered. Another may systematically deny a certain procedure because of a difference in contractual interpretation.

That is why the denial rate becomes truly useful when broken down along three dimensions:

• By payer: reveals which payers account for the most denials and makes it possible to prioritize contract negotiations and process adjustments specific to each one.

• By denial type: separates what has an administrative, technical or clinical origin. Each type requires a different response from management, and treating them all with the same strategy dilutes the effort.

• By department or line of care: identifies whether denials are concentrated in hospital stays, outpatient procedures, oncology or another segment. Departments with greater care complexity tend to generate more clinical denials; departments with a higher volume of billed items tend to concentrate technical and administrative denials.

Segmentation turns the denial rate into a prioritization tool. With it, management knows where to focus training, process review and contract negotiation efforts, without having to act on every front at the same time.

Why monitoring the denial rate protects the revenue cycle

The denial rate is directly connected to the revenue cycle, and its variation usually anticipates financial pressures that show up in cash flow weeks later.

When a claim is denied, it leaves the normal payment flow and enters the appeal process, with its own timeline and an uncertain outcome.

The second effect is on operating cost. Each disputed denial requires staff time to identify the origin, gather documentation and follow up on the payer’s response. When the volume grows, this cost grows with it.

Monitoring the rate monthly makes it possible to identify variations before they pile up. A one-off increase with a given payer may indicate a change in audit criteria or a contractual update that was not incorporated. Caught early, the adjustment is simple. Caught months later, the impact will already have hit cash flow.

A denial rate under control starts before billing

Calculating and monitoring the denial rate is a financial management decision. The number guides where to act: which payer to prioritize, which process to review, which training to bring forward.

Consistently reducing the rate, however, depends on intervening before billing. Denial appeals recover revenue, but they do not eliminate the cost of the process or give back the time lost. Prevention is structurally more efficient.

Rivio automates this layer of pre-billing validation: it cross-checks every charged item against the payer’s contractual rules, identifies coding inconsistencies and flags missing documentation before the claim is submitted. The result is a lower initial denial rate and a revenue cycle with fewer interruptions.

Frequently asked questions about the hospital denial rate

What is an acceptable denial rate for a hospital?

The historical benchmark for the Brazilian private sector was an initial denial rate of 3% to 5% of gross billing. That level has been consistently exceeded since 2022. Each hospital should set its own target, monitored by payer and by denial type, and use the industry comparison as a reference, not a ceiling.

What is the difference between an initial denial and an accepted denial?

The initial denial rate measures everything the payer rejected in the first review of the claim. The accepted denial rate measures what remains as a loss after the appeal process. The difference between the two numbers is the volume of improper denials the hospital managed to reverse.

How often should I calculate the denial rate?

Calculating it monthly makes it possible to identify variations quickly enough to act before the impact on cash flow grows. Hospitals with a high volume of patient care can benefit from biweekly calculations, especially during periods of contract changes or table updates